🔎 Trials Near Me

Utama › Gangguan Mental › New Jersey

Kajian klinikal Gangguan Mental di New Jersey

7 kajian untuk Gangguan Mental sedang mencari peserta di lokasi di New Jersey.

Bandar di New Jersey

Teks kajian rasmi (Bahasa Inggeris)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, West Long Branch
Mengambil pesertaFasa 2
Umur 55 hingga 90 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06887192

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Marlton
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07459647

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • CenExel AMRI, Toms River
Mengambil pesertaFasa 1
Umur 50 hingga 85 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06297590

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Clinilabs, LLC, Eatontown
  • Bio Behavioral Health, Toms River
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 11 Mei 2026 · NCT06524830

A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder

  • Vistagen Clinical Site, Toms River
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 5 Feb 2026 · NCT06809179

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

  • Rutgers University Primary Care Clinics, New Brunswick
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Feb 2026 · NCT06387290

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Toms River
Mengambil pesertaFasa 2
Umur 50 hingga 85 · Semua jantina · Dikemas kini 2 Feb 2026 · NCT07105709

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.